MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹118 Cr |
| Mar2025 | ₹96 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹97 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹118 Cr | 22.73 | |
| Mar2025 | ₹96 Cr | 148.64 | |
| Mar2024 | ₹39 Cr | -61.97 | |
| Mar2023 | ₹102 Cr | 4.73 | |
| Mar2022 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,959.4 Cr | -6.4% | -26.8% | 101.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -6.4% |
-26.8% |
101.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses